Jet Biotech announced that the company plans to expand Investment Management Co., Ltd. to Guangzhou, Yuan Jianhua, Yuan Ye James, and Dannie Yuan to acquire 70% of the shares of Guangdong Jike Membrane Separation Technology Co., Ltd., with a transaction amount of RMB 7.919,900. After the transaction is completed, the company will directly hold 70% of Jieke Membrane's shares, and Jieke Membrane will become a holding subsidiary of the company and will be included in the scope of the company's consolidated statements. The counterparties included Yuan Jianhua, the controlling shareholder of the company, and his co-actors. The transaction constituted a related transaction, but did not constitute a major asset restructuring as stipulated in the “Administrative Measures on Major Asset Restructuring of Listed Companies”.

Jet Biotech announced that the company plans to expand Investment Management Co., Ltd. to Guangzhou, Yuan Jianhua, Yuan Ye James, and Dannie Yuan to acquire 70% of the shares of Guangdong Jike Membrane Separation Technology Co., Ltd., with a transaction amount of RMB 7.919,900. After the transaction is completed, the company will directly hold 70% of Jieke Membrane's shares, and Jieke Membrane will become a holding subsidiary of the company and will be included in the scope of the company's consolidated statements. The counterparties included Yuan Jianhua, the controlling shareholder of the company, and his co-actors. The transaction constituted a related transaction, but did not constitute a major asset restructuring as stipulated in the “Administrative Measures on Major Asset Restructuring of Listed Companies”.